Press Releases September 3, 2026 06:00 AM

Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026

Yuanbao Inc. to Release Q2 2026 Financial Results on September 10 with Earnings Call Scheduled

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
YB

Yuanbao Inc., a technology-driven online insurance distributor in China, announced that it will release its unaudited Q2 2026 financial results on September 10, 2026, prior to the U.S. market open. An earnings call will follow to discuss the results and provide insights into company performance and strategy.

Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026
YB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Yuanbao is a leading online insurance distributor in China leveraging advanced technology to offer customized insurance solutions.
  • The company serves over ten million insurance consumers with a comprehensive service cycle from recommendation to post-sales support.
  • Yuanbao collaborates deeply with insurance carriers to tailor products and improve consumer engagement, driving scalable distribution.

BEIJING, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it will release its second quarter 2026 unaudited financial results on Thursday, September 10, 2026, before the open of the U.S. markets.

The Company’s management will hold an earnings conference call at 8:00 A.M. U.S. Eastern Time on September 10, 2026 or 8:00 P.M. Beijing Time to discuss the financial results.

Participants should complete online registration using the link provided below at least 15 minutes before the scheduled start time. Upon registration, participants will receive the conference call access information, including dial-in numbers, a personal PIN and an e-mail with detailed instructions to join the conference call.

Participant Online Registration:
https://register-conf.media-server.com/register/BI30a562cd1000443a9c1521bedb39a2df

Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at ir.yb-inc.com.

About Yuanbao Inc.

Yuanbao Inc. is a leading technology-driven online insurance distributor in China, committed to protecting health and well-being through innovative technology. Leveraging its proprietary consumer service cycle engine and advanced technologies, Yuanbao delivers customized insurance solutions from its partnered insurance carriers to over ten million insurance consumers throughout the entire insurance lifecycle, ranging from personalized recommendations to post-sales services. Through deep collaboration with insurance carriers and the use of data-driven insights, Yuanbao empowers carriers to tailor flagship products, enhances consumer engagement, and drives scalable and efficient distribution.

For more information, please visit ir.yb-inc.com.

For investor and media inquiries, please contact:

In China:

Yuanbao Inc.
E-mail: [email protected]

Piacente Financial Communications
Helen Wu
Tel: +86-10-6508-0677
E-mail: [email protected]

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]


Risks

  • The company's Q2 2026 financial performance is currently unknown and may impact future stock performance.
  • Operating primarily in the Chinese insurance market exposes Yuanbao to regulatory and market risks within the insurance and technology sectors.
  • The competitive landscape for online insurance distribution in China could impact Yuanbao's growth and profitability.

More from Press Releases

Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference Sep 3, 2026 Ocean Power Technologies Selects Palantir Foundry to Accelerate Growth in Autonomous Maritime Operations Sep 3, 2026 SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company Sep 3, 2026 Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress Sep 3, 2026 60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference Sep 3, 2026